CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-13 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −4,326 | $5.20 | $22K | 0 |
| 2025-10-13 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −4,326 | 417,186 | ||
| 2025-08-26 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +45,632 | $0.06 | $3K | 45,632 |
| 2025-08-26 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −45,632 | $7.01 | $320K | 0 |
| 2025-08-26 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −45,632 | 421,512 | ||
| 2025-08-25 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +2,042 | $0.06 | $123 | 2,042 |
| 2025-08-25 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −2,042 | $5.65 | $12K | 0 |
| 2025-08-25 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,042 | 467,144 | ||
| 2025-08-20 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +2,077 | $0.06 | $125 | 2,077 |
| 2025-08-20 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −2,077 | $5.10 | $11K | 0 |
| 2025-08-20 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,077 | 469,186 | ||
| 2025-08-18 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +2,227 | $0.06 | $134 | 2,227 |
| 2025-08-18 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −2,227 | $5.25 | $12K | 0 |
| 2025-08-18 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,227 | 471,263 | ||
| 2025-08-12 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +5,500 | $0.06 | $330 | 5,500 |
| 2025-08-12 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −5,500 | $5.25 | $29K | 0 |
| 2025-08-12 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,500 | 473,490 | ||
| 2025-08-04 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +5,500 | $0.06 | $330 | 5,500 |
| 2025-08-04 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −5,500 | $5.17 | $28K | 0 |
| 2025-08-04 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,500 | 478,990 |
Page 7 of 12 · 223 trades